Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

280E Tax Code Restrictions on Cannabis Companies Forever?- GOP Senators File Bill to Keep 280E No Matter What Happnes to Weed

Republican Senators James Lankford (Oklahoma) and Pete Ricketts (Nebraska) have introduced a bill that seeks…

7 hours ago

New Blueberry weed strains are about to make wave

New blue hues and flavors from top breeders have arrived. The post New Blueberry weed…

1 day ago

Late-Stage Dementia: Not A Hopeless Case, If You Medicate with Cannabis

While there are many studies showing potential and promise for using various compounds in cannabis…

1 day ago

What Trump’s Cannabis Policy Means for America and the International Markets

Trump's declaration of drug cartels as terrorist organizations and his war cry to ramp up…

2 days ago

Texas Hates Weed…Not! – 62% of Registered Voters Support Cannabis Legalization in the Lone Star State

A recent poll conducted by the University of Houston’s Hobby School of Public Affairs has…

3 days ago